Pacific Sun Financial Corp Purchases 65 Shares of Fidelity NASDAQ Composite Index Tracking Stock ETF (NASDAQ:ONEQ)

Share on StockTwits

Pacific Sun Financial Corp increased its position in shares of Fidelity NASDAQ Composite Index Tracking Stock ETF (NASDAQ:ONEQ) by 7.9% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 883 shares of the company’s stock after buying an additional 65 shares during the quarter. Pacific Sun Financial Corp’s holdings in Fidelity NASDAQ Composite Index Tracking Stock ETF were worth $277,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of ONEQ. B & T Capital Management DBA Alpha Capital Management bought a new position in shares of Fidelity NASDAQ Composite Index Tracking Stock ETF during the third quarter worth about $42,000. Rehmann Capital Advisory Group grew its stake in Fidelity NASDAQ Composite Index Tracking Stock ETF by 32.8% in the second quarter. Rehmann Capital Advisory Group now owns 263 shares of the company’s stock valued at $83,000 after purchasing an additional 65 shares in the last quarter. Marshall Wace LLP bought a new position in Fidelity NASDAQ Composite Index Tracking Stock ETF in the first quarter valued at approximately $131,000. Wealthsource Partners LLC bought a new position in Fidelity NASDAQ Composite Index Tracking Stock ETF in the second quarter valued at approximately $212,000. Finally, Mutual Advisors LLC grew its stake in Fidelity NASDAQ Composite Index Tracking Stock ETF by 10.4% in the third quarter. Mutual Advisors LLC now owns 763 shares of the company’s stock valued at $240,000 after purchasing an additional 72 shares in the last quarter.

ONEQ stock traded up $1.62 during mid-day trading on Friday, reaching $333.62. The company had a trading volume of 28,400 shares, compared to its average volume of 40,243. The stock has a 50 day simple moving average of $319.41 and a two-hundred day simple moving average of $314.79. Fidelity NASDAQ Composite Index Tracking Stock ETF has a 52 week low of $243.01 and a 52 week high of $333.76.

About Fidelity NASDAQ Composite Index Tracking Stock ETF

Fidelity Nasdaq Composite Index Tracking Stock (the Fund) is an exchange-traded fund . The Fund seeks to provide investment returns that closely correspond to the price and yield performance of the NASDAQ Composite Index (the Index). The Fund normally invests at least 80% of assets in common stocks included in the Index .The NASDAQ Composite Index is a market capitalization-weighted index that is designed to represent the performance of NASDAQ securities and includes over 3,000 stocks.

Recommended Story: How to start trading in the forex market?

Want to see what other hedge funds are holding ONEQ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fidelity NASDAQ Composite Index Tracking Stock ETF (NASDAQ:ONEQ).

Institutional Ownership by Quarter for Fidelity NASDAQ Composite Index Tracking Stock ETF (NASDAQ:ONEQ)

Receive News & Ratings for Fidelity NASDAQ Composite Index Tracking Stock ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fidelity NASDAQ Composite Index Tracking Stock ETF and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Metropolitan Life Insurance Co NY Cuts Stake in US Foods Holding Corp
Metropolitan Life Insurance Co NY Cuts Stake in US Foods Holding Corp
Metropolitan Life Insurance Co NY Sells 1,309 Shares of Genesco Inc.
Metropolitan Life Insurance Co NY Sells 1,309 Shares of Genesco Inc.
Allegiance Bancshares Inc  Stake Lifted by Metropolitan Life Insurance Co NY
Allegiance Bancshares Inc Stake Lifted by Metropolitan Life Insurance Co NY
Carvana Co  Shares Sold by Metropolitan Life Insurance Co NY
Carvana Co Shares Sold by Metropolitan Life Insurance Co NY
Metropolitan Life Insurance Co NY Purchases 2,307 Shares of Atara Biotherapeutics Inc
Metropolitan Life Insurance Co NY Purchases 2,307 Shares of Atara Biotherapeutics Inc
Reviewing Oxford BioMedica  and freenet
Reviewing Oxford BioMedica and freenet


© 2006-2019 Ticker Report